Insulin sensitivity in patients with schizophrenia or schizoaffective disorder treated with olanzapine and risperidone
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2011
At a glance
- Drugs Olanzapine; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 01 Aug 2011 Results published in the Diabetes, Obesity and Metabolism.
- 24 Sep 2008 Status changed from recruiting to completed.
- 29 Dec 2005 New trial record.